EP1453547A2
Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 12 November 2022, 3.9 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
5 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| US11931375B2 | Cited by | United States of America | Applicant |
| US12318183B2 | Cited by | United States of America | Applicant |
| US11326182B2 | Cited by | United States of America | Applicant |
| US10335466B2 | Cited by | United States of America | Applicant |
| US11208438B2 | Cited by | United States of America | Applicant |
| US11975056B2 | Cited by | United States of America | Applicant |
| WO2020081490A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| WO2020023612A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| WO2019241486A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| US11298041B2 | Cited by | United States of America | Applicant |
| US11951121B2 | Cited by | United States of America | Applicant |
| US12146150B2 | Cited by | United States of America | Applicant |
| US12319929B2 | Cited by | United States of America | Applicant |
| US11299751B2 | Cited by | United States of America | Applicant |
| WO2020072849A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| US11497576B2 | Cited by | United States of America | Applicant |
| US11193129B2 | Cited by | United States of America | Applicant |
| US11603542B2 | Cited by | United States of America | Applicant |
| US12180500B2 | Cited by | United States of America | Applicant |
| WO2020023612A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| US11434502B2 | Cited by | United States of America | Applicant |
| US11697825B2 | Cited by | United States of America | Applicant |
| US11752181B2 | Cited by | United States of America | Applicant |
| US10983110B2 | Cited by | United States of America | Applicant |
| WO2020072844A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| US10577627B2 | Cited by | United States of America | Applicant |
| US10584337B2 | Cited by | United States of America | Applicant |
| US12116589B2 | Cited by | United States of America | Applicant |
56 members in 11 offices
Priority claims7
| Document | Office | Kind | Date |
|---|---|---|---|
| 341151P | United States of America | – | |
| 34115101 | United States of America | P | |
| 377133P | United States of America | – | |
| 37713302 | United States of America | P | |
| 386122P | United States of America | – | |
| 38612202 | United States of America | P | |
| 0233630 | United States of America | W |
Members56
| Document | Office | Kind | |
|---|---|---|---|
| CA2469785A1 | Canada | A1 | |
| WO03052051A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2002360291A1 | Australia | A1 | |
| AU2002360291A8 | Australia | A8 | |
| US2003228282A1 | United States of America | A1 | |
| WO03052051A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1453547A2This record | European Patent Office (EPO) | A2 | |
| JP2005512533A | Japan | A | |
| EP1453547A4 | European Patent Office (EPO) | A4 | |
| US7282199B2 | United States of America | B2 | |
| US2008075737A1 | United States of America | A1 | |
| US2008075740A1 | United States of America | A1 | |
| US2009227030A1 | United States of America | A1 | |
| US7790449B2 | United States of America | B2 | |
| EP2359869A2 | European Patent Office (EPO) | A2 | |
| JP4810062B2 | Japan | B2 | |
| JP2011254821A | Japan | A | |
| US8318480B2 | United States of America | B2 | |
| US2014004143A1 | United States of America | A1 | |
| EP2359869A3 | European Patent Office (EPO) | A3 | |
| CA2469785C | Canada | C | |
| JP5649529B2 | Japan | B2 | |
| US8962330B2 | United States of America | B2 | |
| US8962332B2 | United States of America | B2 | |
| US2015139953A1 | United States of America | A1 | |
| US2015176027A1 | United States of America | A1 | |
| US2016201088A1 | United States of America | A1 | |
| EP1453547B1 | European Patent Office (EPO) | B1 | |
| US9493788B2 | United States of America | B2 | |
| DK1453547T3 | Denmark | T3 | |
| PT1453547T | Portugal | T | |
| ES2602352T3 | Spain | T3 | |
| US9587250B2 | United States of America | B2 | |
| US2017088858A1 | United States of America | A1 | |
| US9677089B2 | United States of America | B2 | |
| US2017306354A1 | United States of America | A1 | |
| CY1120162T1 | Cyprus | T1 | |
| EP2359869B1 | European Patent Office (EPO) | B1 | |
| US2019017068A1 | United States of America | A1 | |
| DK2359869T3 | Denmark | T3 | |
| PT2359869T | Portugal | T | |
| US10266846B2 | United States of America | B2 | |
| US10301650B2 | United States of America | B2 | |
| ES2717377T3 | Spain | T3 | |
| EP3517134A1 | European Patent Office (EPO) | A1 | |
| US2019292563A1 | United States of America | A1 | |
| US10590435B2 | United States of America | B2 | |
| CY1121446T1 | Cyprus | T1 | |
| US2020283799A1 | United States of America | A1 | |
| US2021348190A1 | United States of America | A1 | |
| US2022025399A1 | United States of America | A1 | |
| US11390883B2 | United States of America | B2 | |
| US11396663B2 | United States of America | B2 | |
| EP3517134B1 | European Patent Office (EPO) | B1 | |
| FI3517134T3 | Finland | T3 | |
| ES2975413T3 | Spain | T3 |
102 legal events, as 16 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Revocation of the patentMA03 | MA03 | AT | |
| Right revoked following opposition or revocationRevokedMF4A | MF4A | EE | |
| Patent revokedRevoked27W | 27W | EP | |
| Annulment of patentMC4A | MC4A | SK | |
| Patent ceasedCeasedPL | PL | CH | |
| Communication despatched that patent is revokedRevokedORIGINAL CODE: EPIDOSNREV1RDAF | RDAF | EP | |
| Patent revokedRevokedORIGINAL CODE: 0009271RDAG | RDAG | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: PATENT REVOKEDSTAA | STAA | EP | |
| Epo's revocation decision now finalR064 | R064 | DE | |
| Patent revoked by epoRevokedR103 | R103 | DE | |
| Information on closure of appeal procedure modifiedAppealORIGINAL CODE: EPIDOSCNOA9OAPAN | APAN | EP | |
| Appeal procedure closedAppealORIGINAL CODE: EPIDOSNNOA9OAPBU | APBU | EP | |
| Opt-out of the competence of the unified patent court (upc) registeredP01 | P01 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| ExpiryMK07 | MK07 | AT | |
| Patent expiredExpiredMK9A | MK9A | IE | |
| Ep patent has lapsedLapsedEUG | EUG | SE | |
| Patent expired because of reaching the maximum lifetime of a patentExpiredMK | MK | BE | |
| Patent expiredExpiredMK4A | MK4A | SK | |
| Patent expired after termination of 20 yearsExpiredPE20 | PE20 | GB | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Patent expired because of reaching the maximum lifetime of a patentExpiredMK | MK | NL | |
| Patent ceasedCeasedPL | PL | CH | |
| Ep patent expiredExpiredEUP | EUP | DK | |
| Expiry of rightR071 | R071 | DE | |
| Appeal reference modifiedAppealORIGINAL CODE: EPIDOSCREFNOAPAH | APAH | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Opposition filed (corrected)OppositionR26 | R26 | EP | |
| Opposition data, opponent's data or that of the opponent's representative modifiedOppositionORIGINAL CODE: 0009299OPPOPLAB | PLAB | EP | |
| Date of receipt of statement of grounds of appeal recordedAppealORIGINAL CODE: EPIDOSNNOA3OAPBQ | APBQ | EP | |
| Appeal reference recordedAppealORIGINAL CODE: EPIDOSNREFNOAPBM | APBM | EP | |
| Date of receipt of notice of appeal recordedAppealORIGINAL CODE: EPIDOSNNOA2OAPBP | APBP | EP | |
| Appeal reference modifiedAppealORIGINAL CODE: EPIDOSCREFNOAPAH | APAH | EP | |
| Appeal reference recordedAppealORIGINAL CODE: EPIDOSNREFNOAPBM | APBM | EP | |
| Date of receipt of notice of appeal recordedAppealORIGINAL CODE: EPIDOSNNOA2OAPBP | APBP | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Reply of patent proprietor to notice(s) of opposition receivedOppositionORIGINAL CODE: EPIDOSNOBS3PLBB | PLBB | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Opposition filedOpposition26 | 26 | EP | |
| Notice of opposition and request to file observation + time limit sentOppositionORIGINAL CODE: EPIDOSNOBS2PLAX | PLAX | EP | |
| Ep patent validated in greeceEP | EP | GR | |
| Opposition filedOppositionORIGINAL CODE: 0009260PLBI | PLBI | EP | |
| Opposition filed against patentOppositionR026 | R026 | DE | |
| Translation of the specification of european patent valid in estoniaFG4A | FG4A | EE | |
| Information on inventor provided after grant (corrected)RIN2 | RIN2 | EP | |
| Information on inventor provided after grant (corrected)RIN2 | RIN2 | EP | |
| Information on inventor provided after grant (corrected)RIN2 | RIN2 | EP | |
| Definitive protectionFG2A | FG2A | ES | |
| Translation is availableAVAILABILITY OF NATIONAL TRANSLATIONSC4A | SC4A | PT | |
| Translation of granted ep patentGrantedTRGR | TRGR | SE | |
| Ep patent with danish claimsT3 | T3 | DK | |
| Translation for ep filed (entry of ep into country)FP | FP | NL | |
| Dpma publication of mentioned ep patent grantGrantedR096 | R096 | DE | |
| Fee paymentPLFP | PLFP | FR | |
| New agentNV | NV | CH | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| Reference to at number (ep patent validated in austria)REF | REF | AT | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE PATENT HAS BEEN GRANTEDSTAA | STAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP |
Showing 100 of 102
Numbers
- Publication
- 1453547
- Application
- 27955392
Titles3
- German
- ADENO-ASSOZIIERTE VIRUS (AAV) SEROTYP 8 SEQUENZEN, DIESE ENTHALTENDE VEKTOREN UND IHRE VERWENDUNG
- English
- ADENO-ASSOCIATED VIRUS (AAV) SEROTYPE 8 SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR
- French
- SEQUENCES DU SEROTYPE 8 DU VIRUS ASSOCIE A L'ADENOVIRUS (AAV), VECTEURS LES CONTENANT ET UTILISATIONS CORRESPONDANTES
Classification
- CPC, 28
- C12N15/86
- A61K48/00
- C07K14/005
- C07K14/755
- C12N7/00
- C12N2750/14122
- C12N2750/14143
- C12N2830/008
- C12N2830/48
- C12N2830/85
- C12Y304/21022
- A61K38/177
- A61K38/45
- A61K38/4846
- C12N9/1018
- C12N9/644
- C12Y201/03003
- C12Y304/21021
- A61P1/18
- A61P11/00
- A61P31/20
- A61P43/00
- A61P7/04
- C12N15/8645
- A61K35/761
- C07K14/705
- C12N2750/14152
- A61K9/0019
- IPC, 17
- C12N15 09
- A61K39 235
- A61K48 00
- A61P1 18
- A61P7 04
- A61P11 00
- A61P31 20
- C07K14 015
- C07K14 755
- C12N1 15
- C12N1 19
- C12N1 21
- C12N5 08
- C12N5 10
- C12N7 00
- C12N7 01
- C12N15 864
Designated states30
- Contracting states, 24
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Ireland
- Italy
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Portugal
- Sweden
- Slovakia
- Türkiye
- Extension states, 6
- Albania
- Lithuania
- Latvia
- North Macedonia
- Romania
- Slovenia